ES240136A1 - Procedure for obtaining physiologically acceptable pharmaceutical compositions (Machine-translation by Google Translate, not legally binding)
- Google Patents
Procedure for obtaining physiologically acceptable pharmaceutical compositions (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries LtdfiledCriticalImperial Chemical Industries Ltd
Priority to ES0240136ApriorityCriticalpatent/ES240136A1/en
Publication of ES240136A1publicationCriticalpatent/ES240136A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Process for obtaining physiologically acceptable pharmaceutical compositions, characterized in that they comprise, as a principle or active principles, 1-methyl-6-nitro-4-quinolone-3-carboxylic acid and the sodium salt thereof, together with non-toxic pharmaceutical excipients and contain, optionally, other known antibacterial agents, as indicated above. (Machine-translation by Google Translate, not legally binding)
ES0240136A1958-02-141958-02-14Procedure for obtaining physiologically acceptable pharmaceutical compositions (Machine-translation by Google Translate, not legally binding)
ExpiredES240136A1
(en)
Procedure for the preparation of new aqueous solutions of adrenocrome monosemicarbazone. (Machine-translation by Google Translate, not legally binding)